Frequently asked questions Is GHK-Cu approved as a medicine?+ How do I handle a 100 mg GHK-Cu vial?+ Can the calculator tell me how to use GHK-Cu topically?+ Why are GHK-Cu vials often larger than other peptides?+ Primary sources Full reference list Background references for this calculator
Dont accept any other treatment
SHOP BY NAME Buy Research Peptides South Africa Browse our full catalogue by compound name
Mechanistic rationale: BPC-157 + GHK-Cu fibroblast activation + collagen signaling, TB-500 + SS-31 vascular protection + mitochondrial resilience
The most commonly reported adverse effects are the GI symptoms associated with tirzepatide (nausea, reduced appetite) plus the mild headache occasionally seen with AOD 9604

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604